Centrica Share Price Slides as JPMorgan Downgrades Stock on Diminishing Upside

Centrica (LON:CNA) is under pressure this morning after JPMorgan downgraded the stock from “Overweight” to “Neutral,” shaving its price target slightly from 170p to 167p. Shares were trading around 160.35p in early London trade, down more than 2%, as investors reassess the company’s near-term potential after years of outperformance.

Massive Rally Fades into Valuation Concerns

The downgrade follows an impressive run, Centrica shares have soared nearly 290% since Q3 2020, driven by aggressive restructuring and a wave of gains during the energy crisis. That rally made it one of the top performers in the sector. But now, analysts believe most of that upside is already priced in. With energy markets stabilizing and the company’s balance sheet no longer a surprise, JPMorgan sees less room for further gains in the near term.

JPMorgan Warns of Slower Growth Ahead

In a note to clients, JPMorgan flagged several key concerns:

  • Most structural tailwinds and pricing advantages have already played out
  • Updated earnings forecasts for 2025 and 2026 now sit 11% and 5% below consensus
  • Ongoing softness in UK Energy Retail and trading segments could weigh on interim results

The broker added that upcoming earnings, set for July 24, will be a pivotal moment for management to show whether growth can continue in a more normalized landscape.

CNA Share Price Outlook

  • Current Price: 160.35p
  • Resistance Levels: 165p, then 170p
  • Support Zones: 155p, followed by 145p
  • MACD Signal: Bearish crossover forming, hinting at possible downside ahead

Can Centrica Hold Its Ground?

Centrica is no longer trading at distressed levels, and that’s precisely the issue. The valuation gap that once attracted deep-value buyers has closed, and in JPMorgan’s view, the stock now faces a more even risk/reward split. Unless July’s results offer a fresh catalyst or energy prices spike again, CNA may struggle to break above resistance.

For investors, the story has shifted from recovery to execution. Whether the company can maintain momentum without external tailwinds will be the big question heading into Q3.

This article is also available in: Polski, Nederlands, हिन्दी, Deutsch, Italiano, Español, Türkçe.